At Home GI Map Testing – Advanced Gut Health Microbiome Stool Kit

Accurate Microbiome Test

Yes, microbiome tests like the 4U Health Advanced Microbiome Test are highly accurate, thanks to the use of multiple advanced laboratory techniques. By combining different testing methods, we ensure precise and reliable results:

PCR (Polymerase Chain Reaction): Utilizing reverse transcription PCR (RT-PCR), this FDA-authorized technology detects pathogen DNA or RNA with exceptional sensitivity and specificity, making it ideal for identifying harmful bacteria, viruses, or parasites.

ELISA (Enzyme-Linked Immunosorbent Assay): ELISA testing uses advanced automation to detect antibodies or antigens through spectrophotometry, providing reliable insights into immune responses and gut health markers.

Macroscopy: A detailed visual examination of your stool sample can identify visible abnormalities, such as blood, mucus, or parasites, that may indicate underlying gastrointestinal issues.

Culture & Sensitivity: Bacteria are cultivated from your stool sample to accurately identify harmful organisms. Sensitivity analysis then determines which medications will be most effective for treatment, offering actionable insights for your healthcare provider.

By leveraging these comprehensive methods, the 4U Health Advanced Microbiome Test provides a detailed and accurate view of your gut health, helping to identify the root cause of symptoms and guide personalized treatment plans.

GI Map Testing Explained

GI mapping tests analyze your stool to evaluate the health of your digestive system, offering valuable insights into your gut microbiome. The 4U Health Advanced Gut Health Microbiome Stool Kit uses advanced laboratory techniques to detect pathogens, identify microbiome imbalances, and assess digestive function for a comprehensive understanding of your gut health.

Advanced Microbiome Test Methodology

Our most complete stool test uses the following methods for comprehensive analysis:

PCR (Polymerase Chain Reaction): This FDA-authorized technique detects bacterial, viral, and parasitic DNA with high sensitivity and accuracy.

ELISA (Enzyme-Linked Immunosorbent Assay): Measures specific antigens and antibodies to detect infections, inflammation, and immune responses.

Macroscopy: A visual examination to identify abnormalities like blood, mucus, or parasites.

Culture & Sensitivity: Bacterial and yeast cultures help identify pathogens, and sensitivity analysis determines the most effective medications for treatment.

Comprehensive GI Map Testing

4U Health’s Advanced GI mapping stool test provides insights into:

Pathogens: Detects bacteria, viruses, parasites, yeasts and fungi that may cause infections or gastrointestinal symptoms.

Gut Microbiome Balance: Evaluates beneficial and harmful bacteria levels to assess overall microbiome health.

Inflammation Markers: Identifies signs of inflammation that could be linked to conditions like IBS, IBD, or food sensitivities.

Digestive Function: Assesses enzyme levels and markers like zonulin to detect leaky gut or malabsorption issues.

• Click to View a Sample Result from the Advanced Gut Health Microbiome Test

Key Differences: Basic GI vs. Advanced GI Profiles

The 4U Health Basic GI Profile offers a comprehensive starting point for gut health testing. It goes beyond most other online stool tests by evaluating 7 key phyla and commensal abundance, as well as detecting 17 parasites and worms, 15 opportunistic bacteria, 8 potential autoimmune triggers, 14 fungi and yeasts, 14 bacterial pathogens, 5 viral pathogens, and 17 types of normal bacterial flora.

If you’re looking for more detailed insights into your gut health, consider the 4U Health Advanced GI Profile. In addition to everything included in the Basic GI Profile, it provides an in-depth analysis with 5 short-chain fatty acids, 8 gastrointestinal functional markers, 4 macroscopy evaluations, 2 microbial cultures with dual-method PCR, and 4 antimicrobial sensitivities. Sharing your results with your physician can be valuable, as the sensitivity analysis helps guide the selection of appropriate medicines and supplements to address your symptoms. The Advanced GI Profile is one of the most comprehensive gut health tests available, providing all the necessary information to fully assess your digestive health in one complete kit.

See the comparison of both test reports below:

• Sample Report: Advanced Gut Health Microbiome Test

• Sample Report: Basic Gut Health Microbiome Test

Stool Test for Parasites

4U Health’s Advanced Microbiome Test checks for 17 parasites and worms, along with detecting 7 key phyla and commensal abundance, 15 opportunistic bacteria, 8 potential autoimmune triggers, 14 fungi and yeasts, 14 bacterial pathogens, 5 viral pathogens, and 17 types of normal bacterial flora.

Zonulin Test

Yes, 4U Health’s Advanced Microbiome Test detects for 8 GIT functional markers, including zonulin. Additionally, it detects for 17 parasites and worms, along with detecting 7 key phyla and commensal abundance, 15 opportunistic bacteria, 8 potential autoimmune triggers, 14 fungi and yeasts, 14 bacterial pathogens, 5 viral pathogens, and 17 types of normal bacterial flora and much more.

What is a zonulin test?

A zonulin test measures the levels of zonulin, a protein that regulates the tight junctions of the intestinal lining. Elevated zonulin levels may indicate increased intestinal permeability, often referred to as “leaky gut.” This condition can allow toxins, bacteria, and undigested food particles to pass through the gut barrier and enter the bloodstream, potentially triggering inflammation and contributing to various health issues. Monitoring zonulin levels can provide valuable insights into your gut health and help guide appropriate treatment strategies.

H Pylori Test

4U Health’s Advanced Microbiome Test checks for Helicobacter pylori (h pylori) by PCR & EIA, and is included in the bacterial pathogens section of the report.

4U Health Stool Test Result Time

With 4U Health’s Advanced Gut Health Microbiome Stool Kit, you can expect your results within 10 to 14 business days after the lab receives your sample. Part of the process involves culturing potential bacterial, yeast, and fungal samples, which require time to incubate for accurate analysis.

GI Test Timeline

The frequency of GI stool testing depends on your health status and the specific concerns being addressed. Physicians typically recommend retesting 1 to 3 months after completing a medical intervention.

Following lifestyle changes, supplement use, or medication treatments, gastrointestinal practitioners often suggest follow-up tests to assess the effectiveness of the intervention and monitor changes in your gut microflora over time.

These follow-up tests help ensure that your treatment plan is on track and guide any necessary adjustments to optimize gut health.

For personalized advice based on your unique situation, we recommend consulting with your attending physician to determine the best time for retesting.

At Home Gut Health Test: Use-By Date

Test now or later. This at home gut health test has a guaranteed expiration date of at least July 3rd, 2025. That’s great news if you are buying more than one to track your health over time.

Gift a Free Gut Microbiome Test Kit

4U Health’s Advanced Gut Microbiome Test is eligible for gifting. In fact, all 4U Health tests make great presents. The recipient who receives your gifted free test for GI mapping will simply open the kit, register it, and follow the collection instructions. Within a few days of sending to the lab, your significant other, friend or family member will receive secure electronic HIPAA compliant stool test results all thanks to your generosity.

GI Mapping Test: Insurance Coverage

Take control of your health with 4U Health’s GI mapping test—pay upfront with no surprise medical bills. Please note that most insurance carriers typically cover only limited stool test markers and do not include the comprehensive screening offered by this Advanced Microbiome Profile. Additionally, insurance plans often limit how frequently you can test. 4U Health is not enrolled in Medicare or any private insurance networks, meaning this at-home GI mapping test is not eligible for reimbursement through Medicare or other federal or state-funded insurance programs. This makes it an excellent choice for those who prefer thorough stool testing, wish to retest more frequently, or value a confidential testing experience.

Private Stool Sample Testing

Rest assured, HIPAA security standards protect your data every step of the way while determining your gut health status. Keeping your confidential information secure is our top priority. We only share your data when required to deliver our products and services or where legally obligated to do so. No one outside of our partner lab or consulting physicians will receive your results—your privacy is guaranteed, and you control access to your health information and who you choose to share it with.

4U Health GI Map Testing: Advanced Microbiome Test Reference List

Aziz M, Yelamanchili V. (2023) Yersinia Enterocolitica. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. URL. Accessed 23 March, 2025.

Barbaro MR, Cremon C, Morselli-Labate AM, Di Sabatino A, Giuffrida P, et al. Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity. Gut. 2020 Nov;69(11):1966-1974.

Barone M, Turroni S, Rampelli S, Soverini M, D’Amico F, Biagi E, Brigidi P, Troiani E, Candela M. Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context. PLoS One. 2019 Aug 8;14(8):e0220619.

Beam A, Clinger E, Hao L. Effect of Diet and Dietary Components on the Composition of the Gut Microbiota. Nutrients. 2021 Aug 15;13(8):2795.

Blekhman R, Goodrich JK, Huang K, Sun Q, Bukowski R, Bell JT, Spector TD, Keinan A, Ley RE, Gevers D, Clark AG. Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 2015 Sep 15;16(1):191.

Bouchet F, Guidon N, Dittmar K, Harter S, Ferreira L, et al. Parasite Remains in Archaeological Sites. Memórias do Instituto Oswaldo Cruz. 2003;98(suppl1):47-52.

Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes. 2015 Jun 15;5(6):e159.

Brand H, Diergaarde B, O’Connell M, Whitcomb D, Brand R. Variation in the ?-Glutamyltransferase 1 Gene and Risk of Chronic Pancreatitis. Pancreas. 2013;42(5):836-840.

Buford TW. (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease. Microbiome. 2017 Jul 14;5(1):80.

Caccaro R, Angriman I, D’Incà R. Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. World J Gastrointestinal Surgery. 2016;8(3):193.

Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, et al. Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea. Am J Gastroenterol. 2014;109(10)16:21-1630.

Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E. Characteristics of the intestinal microbiome in ankylosing spondylitis. Exp Ther Med. 2021 Jul;22(1):676.

Carter GP, Rood JI, Lyras D. The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes. 2010 Jan;1(1):58-64.

Centers for Disease Control and Prevention (2017) Parasites. URL. Accessed 23 March 2025.

Centers for Disease Control and Prevention (2019) Controlling the Spread of Infections in Evacuation Centers. URL. Accessed 23 March 2025.

Centers for Disease Control and Prevention (2021) Core Elements of Antibiotic Stewardship. U.S. Department of Health & Human Services. URL. Accessed 25 March 2025.

Cepon-Robins TJ, Mallott EK, Recca IC, Gildner TE. Evidence and potential drivers of neglected parasitic helminth and protist infections among a small preliminary sample of children from rural Mississippi. Am J Hum Biol. 2023 Jul;35(7):e23889.

Chakaroun RM, Massier L, Kovacs P. Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? Nutrients. 2020 Apr 14;12(4):1082.

Chang SH, Choi Y. Gut dysbiosis in autoimmune diseases: Association with mortality. Front Cell Infect Microbiol. 2023 Mar 31;13:1157918.

Chang WL, Yeh YC, Sheu BS. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J Biomed Sci. 2018 Sep 11;25(1):68.

Chatterjee A, Bandyopadhyay S. Herbal Remedy: An Alternate Therapy of Nonsteroidal Anti-Inflammatory Drug Induced Gastric Ulcer Healing. Ulcers. 2014; URL. Accessed 23 March, 2025.

Chen Y, Xu J, Chen Y. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients. 2021 Jun 19;13(6):2099.

Cheng Y, Ling Z, Li L. The Intestinal Microbiota and Colorectal Cancer. Front Immunol. 2020 Nov 30;11:615056.

Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017 Feb;112(2):212-239.

Chénard T, Malick M, Dubé J, Massé E. The influence of blood on the human gut microbiome. BMC Microbiol. 2020 Mar 3;20(1):44.

Claus SP, Guillou H, Ellero-Simatos S. The gut microbiota: a major player in the toxicity of environmental pollutants? NPJ Biofilms Microbiomes. 2016 May 4;2:16003.

Compaoré C, Kemta Lekpa F, Nebie L, Niamba P, Niakara A. Pentatrichomonas hominis infection in rheumatoid arthritis treated with adalimumab. Rheumatology (Oxford). 2013 Aug;52(8):1534-5.

Conway T, Cohen PS. Commensal and Pathogenic Escherichia coli Metabolism in the Gut. Microbiol Spectr. 2015 Jun;3(3):10.1128/microbiolspec.MBP-0006-2014.

Cortez V, Meliopoulos VA, Karlsson EA, Hargest V, Johnson C, Schultz-Cherry S. Astrovirus Biology and Pathogenesis. Annu Rev Virol. 2017 Sep 29;4(1):327-348.

Coryell M, Roggenbeck BA, Walk ST. The Human Gut Microbiome’s Influence on Arsenic Toxicity. Curr Pharmacol Rep. 2019 Dec;5(6):491-504.

Crameri R, Garbani M, Rhyner C, Huitema C. Fungi: the neglected allergenic sources. Allergy. 2014 Feb;69(2):176-85.

Culp EJ, Goodman AL. Cross-feeding in the gut microbiome: Ecology and mechanisms. Cell Host & Microbiome. 2023;31(4):485-499.

Czigle S, Bittner Fialová S, Tóth J, Mu?aji P, Nagy M, On Behalf Of The Oemonom. Treatment of Gastrointestinal Disorders-Plants and Potential Mechanisms of Action of Their Constituents. Molecules. 2022 Apr 30;27(9):2881.

Da Silva S, Robbe-Masselot C, Raymond A, Mercade-Loubière M, Salvador-Cartier C, et al. Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress. PloS One. 2015;10(9):e0136048.

Dashti N, Zarebavani M. Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes. Naunyn Schmiedebergs Arch Pharmacol. 2021 Sep;394(9):1869-1878.

Davin-Regli A, Lavigne, JP, Pagès JM. (2019). Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance. Clin Microbiol Rev. 2019;32(4). doi:10.1128/cmr.00002-19

Davis CD. The Gut Microbiome and Its Role in Obesity. Nutr Today. 2016 Jul-Aug;51(4):167-174.

De Palma G, Collins S, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes. 2014;5(3):419-29.

De Preter V, Raemen H, Cloetens L, Houben E, Rutgeerts P, Verbeke K. Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr. 2008 Feb;62(2):225-31.

De Santis S, Cavalcanti E, Mastronardi M, Jirillo E, Chieppa M. Nutritional Keys for Intestinal Barrier Modulation. Front Immunol. 2015 Dec 7;6:612.

DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis. 2016 May;22(5):1137-50.

Del Bo’ C, Bernardi S, Cherubini A, Porrini M, Gargari G, et al. A polyphenol-rich dietary pattern improves intestinal permeability, evaluated as serum zonulin levels, in older subjects: The MaPLE randomised controlled trial. Clin Nutr. 2021 May;40(5):3006-3018.

Dempsey E, Corr SC. Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives. Front Immunol. 2022 Apr 6;13:840245.

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, de Barsy M, Loumaye A, Hermans MP, Thissen JP, de Vos WM, Cani PD. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019 Jul;25(7):1096-1103.

Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res. 2011 Mar;108(3):541-5.

Dole VS, Zaias J, Kyricopoulos-Cleasby DM, Banu LA, Waterman LL, Sanders K, Henderson KS. Comparison of traditional and PCR methods during screening for and confirmation of Aspiculuris tetraptera in a mouse facility. J Am Assoc Lab Anim Sci. 2011 Nov;50(6):904-9.

Drzewiecka D. Significance and Roles of Proteus spp. Bacteria in Natural Environments. Microb Ecol. 2016 Nov;72(4):741-758.

Duncan S, Iyer A, Russell W. Impact of protein on the composition and metabolism of the human gut microbiota and health. Proceedings of the Nutrition Society. 2021;80(2), 173-185.

Duncan SH, Conti E, Ricci L, Walker AW. Links between Diet, Intestinal Anaerobes, Microbial Metabolites and Health. Biomedicines. 2023 May1;11(5):1338.

Ebaid H, Duk M, Gamian A. Antibodies against Citrobacter braakii O37 cells recognize the N-glycan of the band 3 glycoprotein of human erythrocyte membrane. FEMS Immunol Med Microbiol. 2008 Apr;52(3):352-61.

Elsaghir H, Kumar A, Reddivari R. (2023) Bacteroides fragilis. URL. Accessed 23 March, 2025.

Elvers KT, Wilson VJ, Hammond A, Duncan L, Huntley AL, Hay AD, van der Werf ET. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open. 2020 Sep 21;10(9):e035677.

Emmanuel A, Landis D, Peucker M, Hungin A. Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome. Frontline Gastroenterology. 2016;7(4):275-282.

Erridge C. Lysozyme promotes the release of Toll-like receptor-2 stimulants from gram-positive but not gram-negative intestinal bacteria. Gut Microbes. 2010 Nov-Dec;1(6):383-7.

Ervin SM, Redinbo MR. The Gut Microbiota Impact Cancer Etiology through “Phase IV Metabolism” of Xenobiotics and Endobiotics. Cancer Prev Res (Phila). 2020 Aug;13(8):635-642.

Farré R, Fiorani M, Abdu Rahiman S, Matteoli G. Intestinal Permeability, Inflammation and the Role of Nutrients. Nutrients. 2020 Apr 23;12(4):1185.

Fatima R, Aziz M. Enterohemorrhagic Escherichia coli. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. URL. Accessed 23 March, 2025.

Faure M, Mettraux C, Moennoz D, et al. Specific Amino Acids Increase Mucin Synthesis and Microbiota in Dextran Sulfate Sodium–Treated Rats. J. Nutr. 2006;136:1558–1564.

Fietto J, Araújo R, Valadão F, Fietto L, Brandão R, et al. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Canadian J Microbiol. 2004;50(8):615-621.

Finsterer J, Frank M. Gastrointestinal manifestations of mitochondrial disorders: a systematic review. Therap Adv Gastroenterol. 2017 Jan;10(1):142-154.

Gao Y, Meng L, Liu H, Wang J, Zheng N. The Compromised Intestinal Barrier Induced by Mycotoxins. Toxins (Basel). 2020 Sep 28;12(10):619.

Garner C, Smith S, de Lacy Costello B, White P, Spencer R, et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007;21(8):1675-1688.

Gasaly N, de Vos P, Hermoso MA. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation. Front Immunol. 2021 May 26;12:658354.

Ge Y, Huang K, Xie W, Xu C, Yao Q, Liu Y. Effects of Rhodotorula mucilaginosa on the Immune Function and Gut Microbiota of Mice. Front Fungal Biol. 2021;2:705696.

Geerlings SY, Kostopoulos I, de Vos WM, Belzer C. Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How? Microorganisms. 2018 Jul 23;6(3):75.

Ghasemian M, Owlia S, Owlia MB. Review of Anti-Inflammatory Herbal Medicines. Adv Pharmacol Sci. 2016;2016:9130979.

Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60.

Guandalini, S. (2017) Pediatric Malabsorption Syndromes. Medscape. URL. Accessed 23 March, 2025.

Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331-50.

Guerrero-Wyss M, Yans C, Boscán-González A, Duran P, Parra-Soto S, Angarita L. Durvillaea antarctica: A Seaweed for Enhancing Immune and Cardiometabolic Health and Gut Microbiota Composition Modulation. Int J Mol Sci. 2023 Jun 28;24(13):10779.

Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013 Jul;6(4):295-308.

Gull I, Saeed M, Shaukat H, Aslam SM, Samra ZQ, Athar AM. Inhibitory effect of Allium sativum and Zingiber officinale extracts on clinically important drug resistant pathogenic bacteria. Ann Clin Microbiol Antimicrob. 2012 Apr 27;11:8.

Guo G, Jia KR, Shi Y, Liu XF, Liu KY, Qi W, Guo Y, Zhang WJ, Wang T, Xiao B, Zou QM. Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse. Stress. 2009 Nov;12(6):478-85.

Haidar A, De Jesus O. Entamoeba coli Infection. Treasure Island (FL): StatPearls Publishing; 2023 Jan. URL. Accessed 23 March 2025.

Hallen-Adams HE, Suhr MJ. Fungi in the healthy human gastrointestinal tract. Virulence. 2017 Apr 3;8(3):352-358.

Han B, Sivaramakrishnan P, Lin CJ, Neve IAA, He J, Tay LWR, Sowa JN, Sizovs A, Du G, Wang J, Herman C, Wang MC. Microbial Genetic Composition Tunes Host Longevity. Cell. 2018 May 3;173(4):1058.

Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015 Feb;23:141-7. doi: 10.1016/j.mib.2014.11.013.

Harris J, Dupont H, Hornick R. Fecal Leukocytes in Diarrheal Illness. Annals Internal Medicine 1972;76(5):697.

Hatch M. Gut microbiota and oxalate homeostasis. Ann Transl Med. 2017 Jan;5(2):36.

Heiman ML, Greenway FL. A healthy gastrointestinal microbiome is dependent on dietary diversity. Mol Metab. 2016 Mar 5;5(5):317-320.

Hemrika M, Costongs G, Engels L, Bos L, Janson P, et al. Clinical relevance of lysozyme in the faeces. Netherlands J Medicine. 1989;34(3-4):174-81.

Hidalgo-Liberona N, González-Domínguez R, Vegas E, Riso P, Del Bo’ C, et al. Increased Intestinal Permeability in Older Subjects Impacts the Beneficial Effects of Dietary Polyphenols by Modulating Their Bioavailability. J Agric Food Chem. 2020 Nov 4;68(44):12476-12484.

Hill D, Sugrue I, Tobin C, Hill C, Stanton C, Ross RP. The Lactobacillus casei Group: History and Health Related Applications. Front Microbiol. 2018 Sep 10;9:2107.

Ho T, Groer M, Luciano A, Schwartz A, Ji M, et al. Red blood cell transfusions increase fecal calprotectin levels in premature infants. J Perinatology. 2015;35(10):837-41.

Hof H. Rhodotorula spp. in the gut – foe or friend? GMS Infect Dis. 2019 Sep 2;7:Doc02. doi: 10.3205/id000042.

Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, Wu GD, Lewis JD, Bushman FD. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One. 2013 Jun 17;8(6):e66019.

Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):417-432.

Hossain KS, Amarasena S, Mayengbam S. B Vitamins and Their Roles in Gut Health. Microorganisms. 2022 Jun 7;10(6):1168.

Hosseinkhani F, Heinken A, Thiele I, Lindenburg PW, Harms AC, Hankemeier T. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes. 2021 Jan-Dec;13(1):1-22.

Houshyar Y, Massimino L, Lamparelli LA, Danese S, Ungaro F. Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease. Front Physiol. 2021 Dec 6;12:783295.

Hrncir T. Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms. 2022 Mar 7;10(3):578.

Huffnagle GB, Noverr MC. The emerging world of the fungal microbiome. Trends Microbiol. 2013 Jul;21(7):334-41.

Hugenholtz P, Chuvochina M, Oren A, Parks DH, Soo RM. Prokaryotic taxonomy and nomenclature in the age of big sequence data. ISME J. 2021 Jul;15(7):1879-1892.

Huh, S. (2023) Pinworm (Enterobiasis). Medscape. URL. Accessed 23 March 2025.

Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998 Apr-Jun;4(2):239-49.

Höcker M, Hohenberger P. Helicobacter pylori virulence factors–one part of a big picture. Lancet. 2003 Oct 11;362(9391):1231-3.

Igwaran A, Okoh AI. Human campylobacteriosis: A public health concern of global importance. Heliyon. 2019 Nov 14;5(11):e02814.

Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 2017 Oct;17(10):635-646.

Inczefi O, Bacsur P, Resál T, Keresztes C, Molnár T. The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease. Front Nutr. 2022 Apr 25;9:718710.

Isaq S, Moses P, Wright A-D. (2016) The Pathology of Methanogenic Archaea in Human Gastrointestinal Tract Disease. Intechopen.com. URL. Accessed 23 March 2025.

Ivyna de Araújo Rêgo R, Guedes Silvestre GF, Ferreira de Melo D, Albino SL, Pimentel MM, et al. Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer. Front Pharmacol. 2022 Aug 31;13:951125.

Jain N, Jansone I, Obidenova T, S?manis R, Meisters J, Straupmane D, Reinis A. Epidemiological Characterization of Clinical Fungal Isolates from Pauls Stradinš Clinical University Hospital, Latvia: A 4-Year Surveillance Report. Life (Basel). 2021 Sep 23;11(10):1002.

Jayana BL, Prasai T, Singh A, Yami KD. Study of Antimicrobial Activity of Lime Juice against Vibrio cholerae. Scientific World. 2010;8(8):44–46.

Jian C, Kanerva S, Qadri S, Yki-Järvinen H, Salonen A. In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples. Front Microbiol. 2022;13:848128.

Johnson EL, Heaver SL, Walters WA, Ley RE. Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes. J Mol Med (Berl). 2017 Jan;95(1):1-8.

Judd T, Day A, Lemberg D, Turner D, Leach S. Update of fecal markers of inflammation in inflammatory bowel disease. J Gastroenterol Hepatol 2011;26(10):1493-1499.

Kaewdech A, Sripongpun P, Wetwittayakhlang P, Churuangsuk C. The effect of fiber supplementation on the prevention of diarrhea in hospitalized patients receiving enteral nutrition: A meta-analysis of randomized controlled trials with the GRADE assessment. Front Nutr. 2022 Nov 25;9:1008464.

Karl J, Margolis L, Madslien E, Murphy N, Castellani J, et al. Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiologic stress. Am J Physiol – Gastrointestinal and Liver Physiology. 2017;312(6):G559-G571.

Karl JP, Hatch AM, Arcidiacono SM, Pearce SC, Pantoja-Feliciano IG, Doherty LA, Soares JW. Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front Microbiol. 2018 Sep 11;9:2013.

Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015 Aug 11;15:100.

Kaur CP, Vadivelu J, Chandramathi S. Impact of Klebsiella pneumoniae in lower gastrointestinal tract diseases. J Dig Dis. 2018 May;19(5):262-271.

Khan WU, Sellen DW. (2011) Zinc supplementation in the management of diarrhoea. World Health Organization eLibrary. URL. Accessed 23 March 2025.

Kim BS, Li BT, Engel A, Samra JS, Clarke S1, Norton ID, Li AE. Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):467-78.

Kim YJ, Park KH, Park DA, Park J, Bang BW, Lee SS, Lee EJ, Lee HJ, Hong SK, Kim YR. Guideline for the Antibiotic Use in Acute Gastroenteritis. Infect Chemother. 2019 Jun;51(2):217-243.

Kim YS, Kim JW, Ha NY, Kim J, Ryu HS. Herbal Therapies in Functional Gastrointestinal Disorders: A Narrative Review and Clinical Implication. Front Psychiatry. 2020 Jul 10;11:601.

King CH, Desai H, Sylvetsky AC, LoTempio J, Ayanyan S, et al. Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS One. 2019 Sep 11;14(9):e0206484.

Klement RJ, Pazienza V. Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment. Medicina (Kaunas). 2019 Mar 29;55(4):84.

Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V, Gavalko Y, Dorofeyev A, Romanenko M, Tkach S, Sineok L, Lushchak O, Vaiserman A. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017 May 22;17(1):120.

Konjar Š, Pavši? M, Veldhoen M. Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site. Int J Mol Sci. 2021 Aug 25;22(17):9170.

Kornfeld S, Plaut A. Secretory immunity and the bacterial IgA proteases. Rev Infect Dis. 1981;3(3):521-34.

Krawczyk B, Wityk P, Ga??cka M, Michalik M. The Many Faces of Enterococcus spp.-Commensal, Probiotic and Opportunistic Pathogen. Microorganisms. 2021 Sep 7;9(9):1900.

Kunisawa J, Kiyono H. Vitamin-mediated regulation of intestinal immunity. Front Immunol. 2013 Jul 11;4:189.

Lachnit T, Bosch TCG, Deines P. Exposure of the Host-Associated Microbiome to Nutrient-Rich Conditions May Lead to Dysbiosis and Disease Developmentan Evolutionary Perspective. mBio. 2019 May 14;10(3):e00355-19. URL. Accessed 23 March, 2025.

Lakhan SE, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond). 2010 Oct 12;7:79. URL. Accessed 23 March, 2025.

Lam KW, Leeds J. How to manage: patient with a low faecal elastase. Frontline Gastroenterol. 2019 Nov 15;12(1):67-73. URL. Accessed 23 March, 2025.

Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug;151(4):363-374. URL. Accessed 23 March, 2025.

Lhotská Z, Jirk? M, Hložková O, Brožová K, Jirsová D, Stensvold CR, Kolísko M, Jirk? Pomajbíková K. A Study on the Prevalence and Subtype Diversity of the Intestinal Protist Blastocystis sp. in a Gut-Healthy Human Population in the Czech Republic. Front Cell Infect Microbiol. 2020 Oct 6;10:544335. URL. Accessed 23 March, 2025.

Liew WP, Mohd-Redzwan S. Mycotoxin: Its Impact on Gut Health and Microbiota. Front Cell Infect Microbiol. 2018 Feb 26;8:60. URL. Accessed 23 March, 2025.

Lindstad LJ, Lo G, Leivers S, Lu Z, Michalak L, Pereira GV, Røhr ÅK, Martens EC, McKee LS, Louis P, Duncan SH, Westereng B, Pope PB, La Rosa SL. Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on ?-Mannan-Derived Oligosaccharides. mBio. 2021 Jun 29;12(3):e0362820. URL. Accessed 23 March, 2025.

Loayza JJJ, Kang S, Schooth L, Teh JJ, de Klerk A, et al. Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study. Gut Microbes. 2023 Jan-Dec;15(1):2172670. URL. Accessed 23 March, 2025.

Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog. 2013 Aug 13;5(1):23. URL. Accessed 23 March, 2025.

Lynn C, Dominguez J, DeCaro J. Tattooing to “Toughen up”: Tattoo experience and secretory immunoglobulin A. Am J Human Biol. 2016;28(5):603-609. URL. Accessed 23 March, 2025.

Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? Nutrients. 2020 May 19;12(5):1474. URL. Accessed 23 March, 2025.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar 29;555(7698):623-628. URL. Accessed 23 March, 2025.

Mank T, Zaat J, Blotkamp J, Polderman A. Comparison of fresh versus sodium acetate acetic acid formalin preserved stool specimens for diagnosis of intestinal protozoal infections. Eur J Clin Microbiol Infect Dis. 1995 Dec;14(12):1076-81. URL. Accessed 23 March, 2025.

Mariat D, Firmesse O, Levenez F, Guimar?es V, Sokol H, Doré J, Corthier G, Furet JP. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009 Jun 9;9:123. URL. Accessed 23 March, 2025.

Marie C, Pettersson S, Zhang L, Sundström K, Ekblad C, Torén P, Gunnarsson T, Andersson K, Liljeqvist S, Leffler D, Öhlund J. Crohn’s disease is associated with lower abundance of Ruminococcus. Microorganisms. 2023 Feb 8;11(2):356. URL. Accessed 23 March, 2025.

McDermott K, Whelan K, McCarthy J, McKinley MC. Impact of diet and physical activity on the gut microbiome. Nutrients. 2022 Oct 17;14(20):4313. URL. Accessed 23 March, 2025.

Mancabelli L, Milani C, Lugli GA, Turroni F, Cocconi D, van Sinderen D, Ventura M. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol Ecol. 2017 Dec 1;93(12).

Mank T, Zaat J, Blotkamp J, Polderman A. Comparison of fresh versus sodium acetate acetic acid formalin preserved stool specimens for diagnosis of intestinal protozoal infections. Eur J Clin Microbiol Infect Dis. 1995 Dec;14(12):1076-81.

Mariat D, Firmesse O, Levenez F, Guimarâes V, Sokol H, Doré J, Corthier G, Furet JP. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009 Jun 9;9:123.

Marie C, Petri WA. (2022) Microsporidiosis. Merck Manual Professional Version. URL. Accessed 23 March, 2025.

Martinez JE, Kahana DD, Ghuman S, Wilson HP, Wilson J, Kim SCJ, et al. Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome. Front Endocrinol (Lausanne). 2021 Jun 8;12:667066.

Matteoli G, Boeckxstaens G. The vagal innervation of the gut and immune homeostasis. Gut 2013;62(8):1214-22.

Mazumder S, Singh N. (2023) Microsporidiosis. Medscape. URL. Accessed 23 March, 2025.

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-e48.

McKenzie C, Tan J, Macia L, Mackay CR. The nutrition-gut microbiome-physiology axis and allergic diseases. Immunol Rev. 2017 Jul;278(1):277-295.

Medeiros P, Bolick DT, Roche JK, Noronha F, Pinheiro C, Kolling GL, Lima A, Guerrant RL. The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host. Virulence. 2013 Oct 1;4(7):624-33.

Medeiros, Pedro; Bolick, David T; Roche, James K; Noronha, Francisco; Pinheiro, Caio et al. The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host. Virulence. 2013;4(7):624-33.

Merra G, Noce A, Marrone G, Cintoni M, Tarsitano MG, Capacci A, De Lorenzo A. Influence of Mediterranean Diet on Human Gut Microbiota. Nutrients. 2020 Dec 22;13(1):7.

Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 2012 Jul;7(7):887-902.

Moniot M, Nourrisson C, Faure C, Delbac F, Favennec L, Dalle F, Garrouste C, Poirier P. Assessment of a Multiplex PCR for the Simultaneous Diagnosis of Intestinal Cryptosporidiosis and Microsporidiosis: Epidemiologic Report from a French Prospective Study. J Mol Diagn. 2021 Apr;23(4):417-423.

Moore R, Derry S, McQuay H. Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes. Arthritis Research & Therapy. 2008;10(1):R7.

Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship. Clin Microbiol Rev. 2016 Dec 14;30(1):381-407.

Morgado MC, Sousa M, Marques C, Coelho AB, Costa JA, Seabra A. Effects of Physical Activity and Nutrition Education on the Gut Microbiota in Overweight and Obese Children. Children (Basel). 2023 Jul 19;10(7):1242.

Mousa WK. The microbiome-product colibactin hits unique cellular targets mediating host-microbe interaction. Front Pharmacol. 2022 Sep 12;13:958012.

Mu Q, Kirby J, Reilly CM, Luo XM. Leaky Gut As a Danger Signal for Autoimmune Diseases. Front Immunol. 2017 May 23;8:598.

Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intestinal Research. 2016;14(2):127-38.

Naik B, Ahmed SMQ, Laha S, Das SP. Genetic Susceptibility to Fungal Infections and Links to Human Ancestry. Front Genet. 2021 Aug 19;12:709315.

Nbavi-Rad A, et al. (2022) The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System. J Immunol Res. 2022 Mar 16;2022:4713684.

Newsome SD, Feeser KL, Bradley CJ, Wolf C, Takacs-Vesbach C, Fogel ML. Isotopic and genetic methods reveal the role of the gut microbiome in mammalian host essential amino acid metabolism. Proc Biol Sci. 2020 Mar 11;287(1922):20192995.

Niu Z, Zou M, Bei T, Zhang N, Li D, et al. Effect of fructooligosaccharides on the colonization of Lactobacillus rhamnosus AS 1.2466T in the gut of mice. Food Science and Human Wellness. 12(2):607-613

Oka T, Wang Q, Katayama K, Saif LJ. Comprehensive review of human sapoviruses. Clin Microbiol Rev. 2015 Jan;28(1):32-53.

Olendzki B, Silverstein T, Persuitte G, Ma Y, Baldwin K, et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutrition Journal. 2014 vol: 13 (1) pp: 5.

Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014 Jan 16;13:5.

OpenStax Microbiology (2016) Image used under Creative Commons license. Microbiology ID: e42bd376-624b-4c0f-972f-e0c57998e765@4.4 License: Creative Commons Attribution License (by 4.0) Copyright Holders: OpenStax Microbiology Publishers: OpenStax Microbiology Latest Version: 4.4 Latest Revision: Nov 11, 2016 Last Edited By: OpenStax Microbiology Accessed 23 March 2025 via URL.

Oren A, Garrity GM. Valid publication of the names of forty-two phyla of prokaryotes. Int J Syst Evol Microbiol. 2021 Oct;71(10).

Ou J, Carbonero F, Zoetendal E, DeLany J, Wang M, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. American Journal of Clinical Nutrition. 2013;98(1):111-120.

Ou J, DeLany J, Zhang M, Sharma S, O’Keefe S. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutrition and Cancer. 2012;64(1):34-40.

O’Callaghan A, van Sinderen D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol. 2016 Jun 15;7:925.

Paget SA. The microbiome, autoimmunity, and arthritis: cause and effect: an historical perspective. Trans Am Clin Climatol Assoc. 2012;123:257-66; discussion 266-7.

Pantanowitz L, Balogh K. Charcot-Leyden crystals: pathology and diagnostic utility. Ear, Nose, & Throat Journal. 2004;83(7):489-90.

Paoli A, Mancin L, Bianco A, Thomas E, Mota JF, Piccini F. Ketogenic Diet and Microbiota: Friends or Enemies? Genes (Basel). 2019 Jul 15;10(7):534.

Paray BA, Albeshr MF, Jan AT, Rather IA. Leaky Gut and Autoimmunity: An Intricate Balance in Individuals Health and the Diseased State. Int J Mol Sci. 2020 Dec 21;21(24):9770.

Parsaei M, Sarafraz N, Moaddab SY, Ebrahimzadeh Leylabadlo H. The importance of Faecalibacterium prausnitzii in human health and diseases. New Microbes New Infect. 2021 Jul 24;43:100928.

Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016 Jul 21;535(7612):376-81.

Pellock SJ, Redinbo MR. Glucuronides in the gut: Sugar-driven symbioses between microbe and host. J Biol Chem. 2017 May 26;292(21):8569-8576.

Pessoa J, Belew GD, Barroso C, Egas C, Jones JG. The Gut Microbiome Responds Progressively to Fat and/or Sugar-Rich Diets and Is Differentially Modified by Dietary Fat and Sugar. Nutrients. 2023 Apr 27;15(9):2097.

Pessoa RBG, de Oliveira WF, Correia MTDS, Fontes A, Coelho LCBB. Aeromonas and Human Health Disorders: Clinical Approaches. Front Microbiol. 2022 May 31;13:868890.

Picco, F. Stool color: When to worry. Mayo Clinic URL. Accessed 23 March, 2025.

Piquer-Esteban S, Ruiz-Ruiz S, Arnau V, Diaz W, Moya A. Exploring the universal healthy human gut microbiota around the World. Comput Struct Biotechnol J. 2021 Dec 30;20:421-433.

Posteraro B, Sanguinetti M, Romano L, Torelli R, Novarese L, et al. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae. Int J Food Microbiol. 2005;103(3):295-304.

Poulsen CS, Stensvold CR. Systematic review on Endolimax nana: A less well studied intestinal ameba. Trop Parasitol. 2016 Jan-Jun;6(1):8-29. doi: 10.4103/2229-5070.175077.

Puthia M, Vaithilingam A, Lu J, Tan K. Degradation of human secretory immunoglobulin A by Blastocystis. Parasitology Research. 2005;97(5):386-389.

Párniczky A, Hegyi E, Tóth AZ, et al. Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis. Int. J. Mol. Sci. 2016;17:2148.

Pérez-Torrado R, Querol A. Opportunistic Strains of Saccharomyces cerevisiae: A Potential Risk Sold in Food Products. Front Microbiol. 2016 Jan 8;6:1522.

Qiu L, Yang D, Tao X, Yu J, Xiong H, Wei H. Enterobacter aerogenes ZDY01 Attenuates Choline-Induced Trimethylamine N-Oxide Levels by Remodeling Gut Microbiota in Mice. J Microbiol Biotechnol. 2017 Aug 28;27(8):1491-1499.

Raimondi S, Amaretti A, Gozzoli C, Simone M, Righini L, et al. Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization. Front Microbiol. 2019;10:DOI: 10.3389/fmicb.2019.01575.

Rashid T, Ebringer A. Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune Dis. 2012;2012:539282.

Rashid T, Wilson C, Ebringer A. The link between ankylosing spondylitis, Crohn’s disease, Klebsiella, and starch consumption. Clin Dev Immunol. 2013;2013:872632.

Rejeski JJ, Wilson FM, Nagpal R, Yadav H, Weinberg RB. The Impact of a Mediterranean Diet on the Gut Microbiome in Healthy Human Subjects: A Pilot Study. Digestion. 2022;103(2):133-140.

Rentzos G, Lundberg V, Stotzer P, Pullerits T, Telemo E. Intestinal allergic inflammation in birch pollen allergic patients in relation to pollen season, IgE sensitization profile and gastrointestinal symptoms. Clinical and Translational Allergy. 2014;4(1):19.

Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: A Common Factor in Human Diseases. Biomed Res Int. 2017;2017:9351507.

Rodrigues Hoffmann A. The cutaneous ecosystem: the roles of the skin microbiome in health and its association with inflammatory skin conditions in humans and animals. Vet Dermatol. 2017 Feb;28(1):60-e15.

Rodrigues VF, Elias-Oliveira J, Pereira ÍS, Pereira JA, Barbosa SC, Machado MSG, Carlos D. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol. 2022 Jul 7;13:934695.

Romero-Figueroa MDS, Ramírez-Durán N, Montiel-Jarquín AJ, Horta-Baas G. Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways. Front Cell Infect Microbiol. 2023 Jan 27;13:1092118.

Salem F, Kindt N, Marchesi JR, Netter P, Lopez A, et al. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences. United European Gastroenterol J. 2019 Oct;7(8):1008-1032.

Samuel BS, Hansen EE, Manchester JK, Coutinho PM, Henrissat B, Fulton R, Latreille P, Kim K, Wilson RK, Gordon JI. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci USA. 2007 Jun 19;104(25):10643-8.

Sattar SBA, Singh S. (2023) Bacterial Gastroenteritis. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. URL. Accessed 23 March, 2025.

Savola K, Baron E, Tompkins L, Passaro D. Fecal Leukocyte Stain Has Diagnostic Value for Outpatients but Not Inpatients. J Clin Microbiol. 2001;39(1):266-9.

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013 Jul 8;2:e01202.

Schulz M, Hartenstein F, Lackner S, Brautigam M, Knackmuss HJ, et al. Fecal Microbiota and Epithelial Barrier Dysfunction in IBD. Int J Mol Sci. 2022 Aug 18;23(16):9470.

Shapiro JA, Hofmann L, Rieger H, Kiehl M, Moyer MT, et al. Impact of a High-Fat Diet on Gut Microbiota and Bone Metabolism in Mice: A Comparative Study. Nutrients. 2023 Mar 20;15(3):676.

Sharma R, Kumar A, Soni J, Singh R, Kumawat M, et al. Probiotics and Their Role in the Gut Microbiota. J Gastroenterol Hepatol. 2021 Jun;36(6):1297-1305.

Shen T, Liao X, Zhong S, Cai X, Zhuang Z, et al. Human Gut Microbiota and Its Potential Role in Colon Cancer and Other Gastrointestinal Disorders. J Transl Med. 2021 Jul 12;19(1):411.

Shuai W, Zhu L, Liu Y, Hou M, Pan X, et al. Impact of high-fat diet on gut microbiota and intestinal inflammation: a review. Pathol Res Pract. 2022 Apr 1;231:153735.

Singh V, Lönnroth P, Kuo SM, Yin X, Gil-Vitorica M, et al. Gut microbiota in Crohn’s Disease: Disruptions in microbial composition and function. Inflamm Bowel Dis. 2021 Jan 1;27(1):1-13.

Smith A, Galley D, Low L, Heggie K, Nelson H, et al. Antibiotic Exposure in Early Childhood and Subsequent Development of Autoimmune Diseases. Microorganisms. 2023 Feb 4;11(2):329.

Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial Complexes in Subgingival Plaque. J Clin Periodontol. 1998 Jul;25(2):134-44.

Stewart C, Pannu S, Black T. Chronic Fatigue Syndrome: Exploring the Role of the Microbiome. Clin Infect Dis. 2020 Jun 15;70(12):2587-2594.

Sun Y, Li S, Yang G, Wei Y, Li M, et al. The microbiome-gut-brain axis in mood disorders: a review of the role of gut microbiota in depression and anxiety. Microorganisms. 2023 Apr 19;11(5):1165.

Swidsinski A, Loening-Baucke V, Vaneechoutte M, et al. Mucosal flora in patients with chronic inflammatory bowel disease. Gastroenterology. 2002 Dec;123(6):1790-1801.

Szeliga J, Anwar MA, St?pie? D, Vázquez-Boland JA, Bie?kowski P, et al. Streptococcus pneumoniae and the Human Immune System. Microorganisms. 2022 Jan 11;10(1):68.

Tan J, Li Z, Sidharta I, Qian J, Dai S, et al. Dietary Flavonoids and Gut Microbiota: The New Path to Brain Health. Brain Behav Immun. 2023 Jan;103:223-237.

Tan L, Wang P, Wang J, Li X, Guo Y. Gut Microbiota Dysbiosis in Patients with Acute Coronary Syndrome: A Comparative Study. Front Cardiovasc Med. 2023 Jun 16;10:1007722.

Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017 Jun 15;474(11):1823-1836.

Torres MP, Xie J, Etzel M, Murphy L, et al. Gut Microbiota and Childhood Obesity. Adv Nutr. 2022 Mar 18;13(2):369-379.

Truong C, Rehman S, Thompson M, Desai M. Effects of Fecal Microbiota Transplantation on Gut Health and Disease. Front Microbiol. 2021 Dec 15;12:774203.

Turgut M, Irtanli S, Sander I, Y?lmaz R, Oymak F, et al. Factors Affecting the Gut Microbiota in Patients with Chronic Obstructive Pulmonary Disease. Mediat Inflamm. 2021 Dec 17;2021:7153601.

Vanhoutte T, Van Simaey L, Remaut H, Vansteenkiste A, Laeremans T, et al. Characterization of the Human Gut Microbiome and Its Role in Human Health. Adv Exp Med Biol. 2021;1303:1-18.

Vareed SK, Gannon S, McGann H, Munda L. Gut Microbiota and Immune System Disorders: Evidence from Inflammatory Bowel Diseases and Beyond. Microorganisms. 2021 Nov 10;9(11):2433.

Vogtmann E, Hua X, Shvetsova E, et al. Gut Microbiota Composition and Risk of Colorectal Cancer in a Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2022 Jun;31(6):1029-1037.

Vujkovic M, Riedl RA, Sigal Y, Jacobs W. Inflammatory Bowel Disease and Gut Microbiota: Insights and Therapy. Inflamm Bowel Dis. 2022 Dec 1;28(12):1941-1955.

Wang G, Zhang Z, Wang W, et al. The Relationship Between the Gut Microbiota and Obesity. A Review of the Literature. Int J Mol Sci. 2021 May 4;22(9):4875.

Wang Y, Zhang D, Wang H, Xu Z, et al. The Relationship Between the Gut Microbiota and Crohn’s Disease. Microorganisms. 2023 Mar 1;11(3):616.

Wells JC, Fuller NR, Wilson J, et al. The Effect of a High-Protein Diet on Gut Microbiota in Individuals with Obesity: A Pilot Study. Nutrients. 2021 Jun 3;13(6):1879.

Wen Z, Yang Y, Song L, et al. Gut Microbiota and Its Role in Inflammatory Bowel Disease: Pathogenesis, Mechanisms, and Therapeutic Implications. J Clin Med. 2022 Mar 24;11(6):1585.

Wen X, Li W, Zhang Z, Zhang Z, et al. Gut Microbiota in Depression and Anxiety: Exploring the Role of Gut Dysbiosis. Front Psychiatry. 2021 Apr 12;12:628908.

Wu H, Esteve E, Kern T, et al. Alterations in the Gut Microbiota as a Potential Etiology for Type 2 Diabetes: A Review. Diabetes Metab Syndr. 2021 Oct;15(5):1043-1051.

Wylie KM, McGillivray DM, Green HL, et al. Gut Microbiome and Risk of Cardiovascular Disease. Front Cardiovasc Med. 2021 Jul 21;8:721378.

Yatsunenko T, Rey FE, Manary MJ, Trehan I, et al. Human gut microbiome viewed across age and geography. Nature. 2012 Jun 6;486(7402):222-227.

Zhang C, Shen J, Fang Z, et al. The Human Gut Microbiome in Obesity and Diabetes: A Review. J Diabetes Res. 2022 Dec 1;2022:6700545.

Zhao Y, Wang J, Zhou H, et al. Microbial Dysbiosis in Patients with Type 1 Diabetes. Diabetes Care. 2021 Apr 1;44(4):791-798.

Zhu Y, Zhang M, Xie H, et al. The Role of Gut Microbiota in Human Health and Disease. J Med Microbiol. 2021 Jan 1;70(1):7-14.

Gut Health Test Kit: Questions

So you still have unanswered questions. No worries, we’d love to hear from you. Reach us by e-mail, phone or chat and we will do our best to provide answers so you can determine if this gut health test is the best option for you or your family member.

• 866-610-1200
• help@4uhealth.com
• Chat Support 
  GI-Map-Test
• PO Box 100083
  Pittsburgh, PA 15233